NASDAQ
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Open
$92.16
Previous Close
$91.85
Day High
$92.18
Day Low
$90.01
52 Week High
$99.50
52 Week Low
$30.82
No price data available for this timeframe.